Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LMS - Leiomyosarcoma”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Early research (Phase 1)Study completedNCT03761095
What this trial is testing

Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Who this might be right for
Leiomyosarcoma
PTC Therapeutics 41
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Not applicableUnknownNCT04935333
What this trial is testing

Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy

Who this might be right for
Leiomyoma, UterineLeiomyosarcoma Uterus
Igenomix 600
Large-scale testing (Phase 3)Ended earlyNCT05269355
What this trial is testing

Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Who this might be right for
Leiomyosarcoma
PTC Therapeutics 359
Testing effectiveness (Phase 2)Ended earlyNCT00414076
What this trial is testing

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Who this might be right for
LeiomyosarcomaUterine Neoplasm
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04727242
What this trial is testing

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

Who this might be right for
LMS - LeiomyosarcomaUterine Leiomyosarcoma
Stanford University 17
Not applicableUnknownNCT04214457
What this trial is testing

Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas

Who this might be right for
LeiomyomaLeiomyosarcoma
Igenomix 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07173972
What this trial is testing

Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma (STS)Soft Tissue Sarcoma AdultSoft Tissue Sarcoma of the Trunk and Extremities+7 more
Oslo University Hospital 40
Not applicableStudy completedNCT00614835
What this trial is testing

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Who this might be right for
Uterine LeiomyosarcomaUterine Cancer
Memorial Sloan Kettering Cancer Center 25
Not applicableLooking for participantsNCT07432932
What this trial is testing

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Who this might be right for
SarcomaSarcoma, Leiomyo-, AdultSarcoma, Synovial, Adult+9 more
Royal Marsden NHS Foundation Trust 800
Testing effectiveness (Phase 2)Ended earlyNCT05116683
What this trial is testing

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Who this might be right for
LeiomyosarcomaLiposarcoma
Benjamin Izar 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114527
What this trial is testing

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Who this might be right for
Soft Tissue Sarcoma
Fox Chase Cancer Center 48
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Active Not RecruitingNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85